• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513860
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/16/2021
Event Type  malfunction  
Manufacturer Narrative
Initial reporter name and address: (b)(6).(b)(4).The device has not been received for analysis.Upon receipt and completion of the problem analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2021 that an ultraflex esophageal ng proximal release covered stent was to be implanted to treat a 6-7cm malignant stricture due to esophageal cancer during an esophageal stent implantation procedure performed on (b)(6) 2021.Reportedly, the patient's anatomy was tortuous and was not dilated prior to stent placement.During the procedure, the stent could not be deployed.The stent was removed from the patient partially covered by the stent deployment suture.The procedure was completed with another ultraflex esophageal stent.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2021 that an ultraflex esophageal ng proximal release covered stent was to be implanted to treat a 6-7cm malignant stricture due to esophageal cancer during an esophageal stent implantation procedure performed on (b)(6) 2021.Reportedly, the patient's anatomy was tortuous and was not dilated prior to stent placement.During the procedure, the stent could not be deployed.The stent was removed from the patient partially covered by the stent deployment suture.The procedure was completed with another ultraflex esophageal stent.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Blocks d4 (lot number and expiration date), and h4 have been updated based on the additional received on january 05, 2022.Block h6: medical device problem code a15 captures the reportable event of partially deployed ultraflex esophageal proximal release stent.Block h10: an ultraflex esophageal proximal release stent and delivery system were received for analysis.Visual inspection found the stent was returned partially deployed.Functional examination was performed by actuating the delivery system (pulled the finger ring with the deployment suture), and the stent was able to fully deploy.No other issues were noted to the stent and delivery system.The reported event of stent was returned partially deployed was confirmed via visual inspection.The investigation concluded that the reported event was most likely due to procedural and/or anatomical factors encountered during the procedure.Additionally, it was reported that the lot number of the device involved during the procedure was used after the expiration date.The device has exceeded the period of time/date recommended by the manufacturer for storing the device without a degradation in quality.Therefore, a review and analysis of all available information indicated the most probable cause is shelf life/expiration date exceeded.A review of the manufacturing documentation for this device revealed that no anomalies or deviations related to the event occurred during manufacturing.Block h11: blocks e1, e2 and e3 have been corrected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key12951700
MDR Text Key281850129
Report Number3005099803-2021-06399
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729716082
UDI-Public08714729716082
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/14/2020
Device Model NumberM00513860
Device Catalogue Number1386
Device Lot Number0022255606
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/13/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/16/2021
Initial Date FDA Received12/07/2021
Supplement Dates Manufacturer Received01/05/2022
Supplement Dates FDA Received01/26/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/15/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age88 YR
Patient SexMale
Patient Weight60 KG
-
-